SecBot SecBot

STXS

Stereotaxis, Inc.
NYSE· Electromedical & Electrotherapeutic Apparatus· Inc. DE· CIK 0001289340 Healthcare & Medical Devices
$0.9900 −0.03 (−2.94%)
Oct 26 4:00 PM ET · prev $1.02
Market cap
$100.0M
Micro cap
Consensus
Buy
89% Buy or better · 9 analysts
Median target
$3.00
+203% · range $3.00–3.00
Next earnings
Nov 10
in 15 days · EPS est. −$0.06
1 year
−67.5%
from $3.05 · Oct 27
30 days
−21.4%
from $1.26
52-week range
$0.9900–3.05
−68% from high · low Oct 21
Avg volume 20D
582.5K
shares / day
Short interest
5.68M
≈5.7% of shares · +1.9%
Days to cover
11.6
at average volume
Insider net
$0
no open-market trades · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
SecBot read MIXED 4 reports · 90 days
Balance 2 bearish · 1 bullish · 1 mixed oldest → newest, height = score
Avg score ·High conf. 3/4 ·Next Earnings date, Nov 10, 2026
Strongest BULLISH Stereotaxis announced that the University of Szeged in Hungary has treated over 70 patients with its Genesis…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.

  • InstitutionsBULLISH

    Q2 2026: 12 added (0 new), 3 trimmed or exited.

  • AnalystsBULLISH

    8 of 9 rate it Buy or better. Every target is above the price.

  • EstimatesFALLING

    Current-quarter EPS estimate −$0.047 → −$0.055 over 90 days. 0 up, 1 down in 30 days.

  • Short sellersSTEADY

    Short interest +1.9% to 5.68M shares. 11.6 days to cover, ≈5.7% of shares.

  • TrendDOWNTREND

    21% below its 50-day average. New closing low $0.9900 on Oct 26.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
VANGUARD PORTFOLIO MANAGEMENT LLCADD463,580$797.4K
MORGAN STANLEYDOUBLED332,107$571.2K
SEI INVESTMENTS COTRIM234,612$403.5K
BANK OF AMERICA CORP /DE/DOUBLED117,318$201.8K
ENVESTNET ASSET MANAGEMENT INCTRIM91,578$157.5K
DEUTSCHE BANK AG\DOUBLED67,537$116.2K
WELLS FARGO & COMPANY/MNDOUBLED62,191$107.0K
Verition Fund Management LLCADD35,000$60.2K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

9 analysts
Buy 89% rate it Buy or better
Strong Buy2Buy6Hold1Sell0Strong Sell0
12-month targets · 3 analysts

Price is below the lowest target. Median implies +203%.Targets as of Oct 26, 2026.

Recent actions
DateFirmActionRating
Aug 27, 2026Citizens
MAINTAIN
MAINTAINMarket Outperform
Aug 12, 2026TD Cowen
MAINTAIN
MAINTAINBuy
May 13, 2026Piper Sandler
REITERATE
REITERATEOverweight

Insider ledger

Form 4
$0
open-market buys or sells · 12 mo
DateInsiderTypeValue
Jul 1, 2026
Benfer David
Director
AWARD43,103 sh
Jul 1, 2026
Levin Ross B
Director
AWARD43,103 sh
Jul 1, 2026
Fischel Nathan
Director
AWARD43,103 sh
Jul 1, 2026
Menawat Arun Swarup
Director
AWARD43,103 sh
Jul 1, 2026
SHAMIR NACHUM
Director
AWARD43,103 sh
Jul 1, 2026
Curet Myriam
Director
AWARD43,103 sh
Apr 11, 2026
Peery Kimberly R.
Chief Financial Officer
AWARD40,000 sh

Earnings setup

Estimates
Nov 10
reports in 15 days
−$0.06
EPS estimate, this quarter
−18%
estimate change, 90 days
0↑ 1↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.06-$0.06–-$0.05-17.8%$9.6M
Next Q-$0.04-$0.05–-$0.04-35.0%$10.7M
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Short side

FINRA· Sep 30, 2026
5,681,816
shares short
+1.9%
vs prior settlement
11.6
days to cover
≈5.7%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 22, 2026 Other
Stereotaxis Announces First Robotic Magnetic Navigation System in Latvia
Pauls Stradiņš Clinical University Hospital installs Genesis Robotic Magnetic Navigation System, est
Sep 3, 2026 Press
Stereotaxis announced that the University of Szeged in Hungary has treated over 70 patients with its Genesis Robotic…
Impact 5/10
Aug 14, 2026 SEC
Stereotaxis' S-3 shelf registration (File No. 333-297485) became effective on August 13, 2026, enabling the company to…
EFFECT — Impact 6/10
Aug 14, 2026 SEC
Stereotaxis' S-3 resale shelf registration (File No. 333-297484) covering 108,868,331 shares held by selling…
EFFECT — Impact 5/10
Aug 11, 2026 SEC
Stereotaxis reported Q2 2026 revenue of $7.7M, missing consensus of $8.3M, and EPS of -$0.06, missing consensus of…
PRESS-RELEASE — Impact 6/10
Jul 1, 2026 Insider
Benfer David was granted 43,103 shares
Director
Jul 1, 2026 Insider
Levin Ross B was granted 43,103 shares
Director
Jul 1, 2026 Insider
Fischel Nathan was granted 43,103 shares
Director
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 10, 2026
Earnings date
STXS Q3 2026 Earnings After Market Close — 2026-11-10
Recent
Oct 22, 2026
Press release
Stereotaxis Announces First Robotic Magnetic Navigation System in Latvia
Pauls Stradiņš Clinical University Hospital installs Genesis Robotic Magnetic Navigation System, establishing the first robotic program for the…
Sep 16, 2026
Press release
Stereotaxis Emerging Digital, AI and Automation Capabilities to be Featured at Heart Rhythm Society’s HRX 2026
ST. LOUIS, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive…
Sep 15, 2026
Short interest
Short Interest: STXS up 10% to 5.6M shares
Settlement 2026-09-15 | Days to cover: 10.09 | ≈5.57% of shares outstanding (est.)
Sep 3, 2026
FDA
University of Szeged Celebrates Strongest First Month of Robotic Cardiology Program
ST. LOUIS, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive…
Aug 14, 2026
Short interest
Short Interest: STXS up 20% to 5.4M shares
Settlement 2026-08-14 | Days to cover: 7.04 | ≈5.37% of shares outstanding (est.)

SecBot reports

13 filings · 3 press releases · 0 bullish · 5 bearish · 4 mixed · 4 neutral
All STXS filing & press-release reports (16)